An investigation on behalf of investors in Integra LifeSciences Holdings Corporation (NASDAQ:IART) shares over potential wrongdoing at Integra LifeSciences Holdings Corporation was announced and NASDAQ:IART stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 07/31/2023 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors at Integra LifeSciences Holdings Corporation.
Investors who purchased shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Integra LifeSciences Holdings Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders.
Princeton, NJ based Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. On May 23, 2023, Integra LifeSciences Holdings Corporation announced that it had conducted an internal investigation, leading to a global recall of all products produced at its Boston, Massachusetts facility. The affected products were distributed between March 1, 2018, and May 22, 2023. Integra LifeSciences Holdings Corporation ceased manufacturing operations at the facility. The reason behind these actions was the company "identified deviations with endotoxin testing that may have resulted in the release of products with higher levels of endotoxins than permitted by the product specifications."
Shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) declined from $50.87 per share on May 22, 2023, to as low as $37.44 per share on May 31, 2023.
Those who purchased shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.